📰 3 sources covering this story

Novartis Pauses Autoimmune Cell Therapy Studies After Deaths - WSJ

First covered 5 hrs ago · latest take 4 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Novartis Pauses Autoimmune Cell Therapy Studies After Deaths - WSJ
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths - WSJ
Novartis Pauses Autoimmune Cell Therapy Studies After Deaths  WSJ
Reuters
Reuters4 hrs ago
Novartis pauses trials of experimental cell therapy after three deaths
Novartis pauses trials of experimental cell therapy after three deaths  Reuters
STAT News
STAT News🏁 first to report5 hrs ago
STAT+: Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more
Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine price for a cancer drug. Read the latest pharma headlines in today's…
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →